Prioritizing precision medicine in pulmonary hypertension
The Center for Pulmonary Vascular Biology and Medicine at the University of Pittsburgh and UPMC is a multi-disciplinary clinical and research center for pulmonary vascular disease with a focus on comprehensive and state-of-the-art care of our patients.
In the past, pulmonary hypertension (PH) was considered a rare disease affecting only a few unfortunate people. Today, we know countless individuals suffer from this disease with tragic consequences. But because PH has been an historically neglected disease, advances have been slowed by the lack of sophisticated technology, little financial support, and a small number of physicians and scientists dedicated to its study.
The Center for Pulmonary Vascular Biology and Medicine is devoted to accelerating discoveries about this disease and ensuring these discoveries are applied directly to improve the lives of our patients. We focus our efforts on innovative ways to identify this disease early such that prevention of this disease may be a reality, to identify the elusive molecules that lie at the beginning origins of this disease, and to develop new treatments that could reverse or cure this disease. Inherent to this mission is improving PH awareness and partnership within our community so that we can combat this disease together.
By combining computational and experimental approaches, University of Pittsburgh School of Medicine and Prairie View A&M University researchers identified cancer drugs that show promise for treating pulmonary hypertension, or PH, a rare and incurable lung disease....
The Chan Lab’s work on BOLA3 and pulmonary hypertension was selected as a 2019 top research advance by the AHA in heart disease and stroke!
2019 UPMC Pulmonary Hypertension Patient Research Day! We are inspired by our patients and look forward to a day when this disease is cured. Learn how researchers and doctors are sharing their resources to help patients with pulmonary hypertension.